Stocks surged on Friday, with the S&P 500 soaring 2.13% as investors welcomed a break from tariff-driven turmoil. The market ...

German drugmaker Boehringer Ingelheim has its first regulatory approval for spesolimab, its antibody therapy for rare and life-threatening skin disorder generalised pustular psoriasis (GPP), in ...

Other potential disease targets include palmoplantar pustulosis, generalised pustular psoriasis and pyoderma gangrenosum. Several further phase 2 trials are planned soon, the company said.

Join Drs Steven Feldman and Robert Kushner as they discuss the role of dermatologists in treating obesity in conjunction with psoriasis.

In the treatment of psoriasis, preliminary evidence supports the hypothesis that IL-23 inhibitors are capable of extended remissions and protection against PsA relative to other biologics.

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Biotechnology industry for Monday, March 17, 2025. Let’s take a ...

Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on ...

Whether you’re just starting psoriasis treatment or are looking for more effective therapies for your symptoms, it helps to remember these important steps to take — and to avoid. If you’re ...

The approval is based on results from an open-label, phase 3 clinical trial testing the safety, efficacy, pharmacodynamics, and pharmacokinetics of eculizumab in pediatric patients with refractory ...

Hemophagocytic lymphohistiocytosis, a severe hyperinflammatory condition, can complicate FNAIT, making early diagnosis critical. Hemophagocytic lymphohistiocytosis (HLH), a life-threatening ...

Former CDC employees argued their terminations were unlawful. HealthDay News — A group of former U.S. Centers for Disease Control and Prevention (CDC) employees is fighting to get their jobs back ...

Nearly half of respondents did not know about the prevalence, risks, or symptoms of HPV, especially as it pertains to men. HealthDay News — The majority of people are unaware that the human ...